Madrigal Pharmaceuticals (NasdaqGS:MDGL) FY Conference Transcript

Madrigal Pharmaceuticals (NasdaqGS:MDGL) FY Conference January 12, 2026 04:30 PM ET Company ParticipantsMardi Dier - CFODavid Soergel - CMOBill Sibold - CEOConference Call ParticipantsNone - AnalystNoneGood afternoon, everyone, and welcome. I'm Pradyumna from JPMorgan's healthcare team. Thank you for joining us for the Madrigal Pharmaceuticals presentation today. Madrigal has been one of the most consequential companies in the metabolic and liver disease over the last few years, and today, we're pleased to ...